Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.
Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E.
Cherfils-Vicini J, et al.
EMBO J. 2019 Jun 3;38(11):e100012. doi: 10.15252/embj.2018100012. Epub 2019 Apr 18.
EMBO J. 2019.
PMID: 31000523
Free PMC article.